Conjugated equine estrogens and estradiol benzoate differentially modulate the natriuretic peptide system in spontaneously hypertensive rats

Menopause

Volumn 20, Issue 5, 2013, Pages 554-560

  Firmes, Luciana Barbosa ^a   Belo, Najara Oliveira ^a,b   Reis, Adelina Martha ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Atrial natriuretic peptide; Conjugated equine estrogens; Estradiol; Hypertension; Menopause

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL BENZOATE; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR C;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DECAPITATION; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HYPERTENSION; NONHUMAN; OVARIECTOMY; PLETHYSMOGRAPHY; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYNTHESIS; TAIL;

ADIPOSE TISSUE; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WEIGHT; ESTRADIOL; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; GENE EXPRESSION; HEART ATRIA; KIDNEY; MESENTERY; OVARIECTOMY; RATS; RATS, INBRED SHR; RATS, WISTAR; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, MESSENGER;

EID: 84879241987     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318276c4cc     Document Type: Article

References (46)

1. Chappell MC, Gallagher PE, Averill D.B., Ferrario CM, Brosnihan KB Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat. Hypertension 2003; 42:781-786.
2. Scuteri A, Bos AJ, Brant L.J., Talbot L., Lakatta EG, Fleg JL Hormone replacement therapy and longitudinal changes in blood pressure in post-menopausal women. Ann Intern Med 2001; 135:229-234.
3. Miller VM, Kaplan JR, Schork N.J., et al Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol Sex Differ 2011; 2:14.
4. The North American Menopause Society. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012; 19:257-271.
5. Dubey RK, Oparil S, Imthurn B., Jackson EK Sex hormones and hypertension. Cardiovasc Res 2002; 53:688-708.
6. Rossouw JE, Anderson GL, Prentice R.L., LaCroix AZ, Kooperberg C, Stefanick ML Working Group for the Women's Health Initiative Investigators: risk and benefits of oestrogen plus progestin in healthy post-menopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288:321-333.
7. Anderson GL, Limacher M, Assaf A.R., et al Effects of conjugated equine estrogens in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291:1701-1712.
8. Smith ML, Heckbert SR, Lemaitre RN Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004; 292:1581-1587.
9. Karjalainen AH, Ruskoaho H, Vuolteenaho O., et al Effects of estrogen replacement therapy on natriuretic peptides and blood pressure. Maturitas 2004; 47:201-208.
10. Belo NO, Silva-Barra J, Carnio E.C., Antunes-Rodrigues J, Gutkowska J, Dos Reis AM. Involvement of atrial natriuretic peptide in blood pressure reduction induced by estradiol in spontaneously hypertensive rats. Regul Pept 2004; 117:53-60.
11. Gilligan DM, Badar DM, Panza J.A., Quyyumi AA, Cannon RO Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90:786-791.
12. Lieberman EH, Gerhard MD, Uehata A, et al Estrogen improves endothelium-dependent, flow mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121:936-941.
13. Lang R, Tholken H, Ganten D., Luft FC, Ruskoaho H, Unger T Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 1985; 314:264-266.
14. Cohen D, Koh GY, Nikonova L.N., Porter JG, Maack T. Molecular determinants of the clearance function of type C receptors of natriuretic peptides. J Biol Chem 1996; 271:9863-9869.
15. De Bold A.J., Boreiinstein HB, Veress A.T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28:89-94.
16. Levin ER, Gardner DG, Samson WK Mechanisms of disease: natriuretic peptides. N Engl J Med 1998; 339:321-327.
17. Gutkowska J, Genest J, Thibault G., Garcia R, Larochelle P, Cusson JR Circulating forms and radioimmunoassay of natriuretic factor. Endo-crinol Metab Clin North Am 1987; 16:183-198.
18. Brosnihan KB, Moriguchi A, Nakamoto H., Dean RH, Ganten D, Ferrario CM Estrogen augments the contribution of nitric oxide to blood pressure in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am J Hypertens 1994; 7:576-582.
19. Maffei S, Del RS, Prontera C, et al Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in post-menopausal women. Clin Sci 2001; 101:447-453.
20. Deng Y, Kaufman S. The influence of reproductive hormones on ANF release by rat atria. Life Sci 1993; 53:689-695.
21. Zhang Y, Novak K. Atrial natriuretic factor release during pregnancy in rats. J Physiol 1995; 488:509-514.
22. Belo NO, Sairam MR, Reis A M. Impairment of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for obesity-associated hypertension in menopause. Endocrinology 2008; 149:1399-1406.
23. Jankowski M, Rachelska G, Donghao W., McCann SM, Gutkowska J. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc Natl Acad Sci U S A 2001; 98:11765-11770.
24. Hong M, Yan Q, Tao B., et al Estradiol, progesterone and testosterone exposures affect the atrial natriuretic peptide gene expression in vivo in rats. Biol Chem Hoppe-Seyler 1992; 373:213-218.
25. Cagnacci A, Rovati L, Zanni A., Malmusi S, Facchinetti F, Volpe A. Physiological doses of estradiol decrease nocturnal blood pressure in normo-tensive postmenopausal women. Am J Physiol 1999; 276:H1355-H1360.
26. Canonico M, Oger E, Plu-Bureau G, et al Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115:840-845.
27. Feeman WEJ. Thrombotic stroke in an otherwise healthy middle-aged female related to the use of continuous-combined conjugated equine estrogens and medroxyprogesterone acetate. J Gend Specif Med 2000; 3: 62-64.
28. Shifren JL, Rifai N, Desindes S., McIlwain M, Doros G, Mazer NA A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab 2008; 93:1702-1710.
29. Zhu BT, Han GZ, Shim J.Y., Wen Y., Jiang XR Quantitative structure activity relationship of various endogenous estrogen metabolites for human estrogen receptor α and β subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 2006; 147: 4132-4150.
30. Isaksson E, Wang H, Sahlin L., et al Expression of estrogen receptors (α, β) and insulin-like growth factor-1 in breast tissue form surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast 2002; 11:295-300.
31. Jazbutyte V, Arias-Loza PA, Hu K., et al Ligand-dependent activation of ERA lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res 2008; 77:774-781.
32. Hernandez I, Delgado JL, Díaz J, et al 17A-Estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol 2000; 279:R1599-R1605.
33. Andreollo NA, Santos EF, Araujo M.R., Lopes LR Rat's age versus human's age: what is the relationship? Arq Bras Cir Dig 2012; 25:49-51.
34. Cagnacci A, Rovati L, Zanni A., Malmusi S, Facchinetti F, Volpe A. Physiological doses of estradiol decrease nocturnal blood pressure in normo-tensive postmenopausal women. Am J Physiol 1999; 276:H1355-H1360.
35. Seely EW, Walsh BW, Gerhard M.D., Williams GH Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999; 33:1190-1194.
36. Yamamoto T, Feng L, Mizuno T., et al Expression of mRNA for natri-uretic peptide receptor subtypes in bovine kidney. Am J Physiol 1994; 267:F318-F324.
37. Neves LA, Chappell MC, Ferrario C.M., Gallagher PE, Ganten D, Brosnihan KB Effect of estrogen on neprilysin expression in uterus and kidney of Sprague Dawley normotensive and heterozygous (mRen2)27-transgenic hypertensive rats. Peptides 2006; 27:2912-2918.
38. Pinto FM, Armesto CP, Magraner J, Trujillo M., Martin JD, Candenas ML Tachykinin receptor and neutral endopeptidase gene expression in the rat uterus: characterization and regulation in response to ovarian steroid treatment. Endocrinology 1999; 140:2526-2532.
39. Liu KH, Chan YL, Chan W.B., Kong WL, Kong MO, Chan JC Sono-graphic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperi-toneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes Relat Metab Disord 2003; 27:1267-1273.
40. Kannel WB, Cupples LA, Ramaswami R, Stokes J III, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease, the Framingham Study. J Clin Epidemiol 1991; 44:183-190.
41. de Souza Santos Machado V, Valadares AL, da Costa-Paiva LS, Moraes SS, Pinto-Neto AM. Multimorbidity and associated factors in Brazilian women aged 40 to 65 years: a population-based study. Menopause 2012; 19:569-575.
42. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008; 26:831-843.
43. Sarzani R, Marcucci P, Salvi F., et al Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int J Obes 2008; 32:259-267.
44. Wang TJ, Larson MG, Levy D, et al Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109:594-600.
45. Nishikimi T, Iemura-Inaba C, Akimoto K., Ishikawa K, Koshikawa S, Matsuoka H. Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/Gi pathways in rat cultured adipocytes. Regul Pept 2009; 153:56-63.
46. Sengenès C., Berlan M, De Glisezinski I, Lafontan M, Galitzky J. Natri-uretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 2000; 14:1345-1351. Aperfeiçoamento de Pessoal de Nível Superior